Research Roundup

Debbie Rigby rounds up the latest in research news Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes A large systematic review and network meta-analysis of 764 randomised controlled trials has concluded that SGLT-2 inhibitors and GLP-1 receptor agonists reduced cardiovascular and renal outcomes in patients with type 2

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The debate goes on
Next Time running out on APP2021 Super Early Bird savings